The COVID-19 Monitoring and Assessment Program (MAP) was created in spring 2020 to develop and expand the university’s testing capacity for the coronavirus that causes COVID-19.
The program leverages the research strengths of the UO, including experts in genomics, data science, prevention science, and other areas.
The MAP team has expanded testing capacity to about 4,000 tests per week. All asymptomatic residents of Lane County are invited to participate in testing. We particularly encourage students living off campus in group or apartment living settings, faculty and employees whose work requires them to be on campus, and underserved communities disproportionately impacted by COVID-19 to sign up for testing.
Pre-registration is encouraged via the MAP registration portal, which is updated every week with available testing slots for the following week.
MAP Tests Provided
Develop a fully operational clinical laboratory improvement amendments (CLIA)-certified testing laboratory on campus.
Create test collection and test processing systems to provide capacity for screening and surveillance testing for COVID-19 at UO and its surrounding community.
Use the results of the testing to develop strategies that local officials and university leaders can enact to suppress the spread of COVID-19 as activity and population changes occur.
Sample Collection Methods
- Self-collected saliva—in use
- Self-collected shallow nasal swab (anterior nares)—in use
- Deep nasal swab—approved, but not in use
Sample Processing Methods
TaqMan quantitative PCR (qPCR) – in use
Genotyping by RNA sequencing, and high throughput RNA-seq of entire viral genomes—in use
Saliva Direct—in use
SwabSeq—optimization in process but not yet approved